(Q37816501)

23 August 2017

1 reference

title

Alternative pre-mRNA splicing in digestive tract malignancy (English)

1 reference

23 August 2017

1

0 references

Wataru Fujibuchi

series ordinal

2

object named as

Wataru Fujibuchi

1 reference

23 August 2017

3

Iwao Sasaki

1 reference

23 August 2017

7 December 2010

1 reference

23 August 2017

1 reference

23 August 2017

102

1 reference

23 August 2017

2

1 reference

23 August 2017

309-316

1 reference

Alternative splicing: new insights from global analyses

23 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01797.X

Finishing the euchromatic sequence of the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01797.X

ASAP: the Alternative Splicing Annotation Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01797.X

Mechanisms of alternative pre-messenger RNA splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01797.X

Cancer-associated splicing variants of the CDCA1 and MSMB genes expressed in cancer cell lines and surgically resected gastric cancer tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01797.X

The spliceosome: design principles of a dynamic RNP machine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01797.X

hnRNP complexes: composition, structure, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01797.X

Alternative splicing: an emerging topic in molecular and clinical oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01797.X

Distinct functions of SR proteins in alternative pre-mRNA splicing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01797.X

Alternative splicing: multiple control mechanisms and involvement in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01797.X

ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01797.X

Building specificity with nonspecific RNA-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01797.X

Alternative splicing resulting in nonsense-mediated mRNA decay: what is the meaning of nonsense?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01797.X

The spliceosome as target for anticancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01797.X

Nomenclature for the description of human sequence variations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01797.X

E-cadherin germline mutations in familial gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01797.X

Altered expression of the fragile histidine triad gene in primary gastric adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01797.X

A novel splice-site variant of the base excision repair gene MYH is associated with production of an aberrant mRNA transcript encoding a truncated MYH protein not localized in the nucleus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01797.X

Splice-site genetic polymorphism of the human kallikrein 12 (KLK12) gene correlates with no substantial expression of KLK12 protein having serine protease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01797.X

Disruption of an exon splicing enhancer in exon 3 of MLH1 is the cause of HNPCC in a Quebec family

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01797.X

Aberrant splicing in MLH1 and MSH2 due to exonic and intronic variants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01797.X

In silico and in vivo splicing analysis of MLH1 and MSH2 missense mutations shows exon- and tissue-specific effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01797.X

Familial adenomatous polyposis: aberrant splicing due to missense or silent mutations in the APC gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01797.X

Alternative splicing and nonsense-mediated mRNA decay in the regulation of a new adenomatous polyposis coli transcript.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01797.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01797.X

Editing of hnRNP K protein mRNA in colorectal adenocarcinoma and surrounding mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01797.X

B-Raf(V600E) cooperates with alternative spliced Rac1b to sustain colorectal cancer cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01797.X

Antagonistic SR proteins regulate alternative splicing of tumor-related Rac1b downstream of the PI3-kinase and Wnt pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01797.X

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01797.X

cIAP2 as a therapeutic target in colorectal cancer and other malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01797.X

Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01797.X

Alternative splice variants of survivin as potential targets in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01797.X

Activation of tumor-specific splice variant Rac1b by dishevelled promotes canonical Wnt signaling and decreased adhesion of colorectal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01797.X

Rac1, but not Rac1B, stimulates RelB-mediated gene transcription in colorectal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01797.X

The anti-angiogenic isoforms of VEGF in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01797.X

VEGF-A splicing: the key to anti-angiogenic therapeutics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01797.X

Targeted mRNA degradation by double-stranded RNA in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01797.X

Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01797.X

Splicing factor SF3b as a target of the antitumor natural product pladienolide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01797.X

Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01797.X

Manipulation of alternative splicing by a newly developed inhibitor of Clks

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01797.X

Deciphering the splicing code

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01797.X

Intragenic deletion of CDH1 as the inactivating mechanism of the wild-type allele in an HDGC tumour

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01797.X

10.1111/J.1349-7006.2010.01797.X

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference

PubMed ID

21134075